Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer
2011 ◽
Vol 133
(1)
◽
pp. 145-159
◽
2021 ◽
Keyword(s):
2010 ◽
Vol 8
(3)
◽
pp. 60
◽
2011 ◽
2012 ◽
2016 ◽
2020 ◽